Colon cancer screening is only effective if you complete the test. With 53,000 Americans expected to die from colon cancer in ...

Older adults on Medicare Advantage had improved adherence and odds of a test return when a stool test was mailed to them for ...

The prospect causes some to skip the screening. Due to these qualms, doctors also offer stool tests to screen for colon cancer. These tests, taken once a year, can help keep tabs on a person's ...

A non-invasive, easy-to-use test, like the Cologuard test, is a simple and effective way to screen for colorectal cancer. In ...

Cases of colorectal cancer have been rapidly increasing among young adults, so we spoke to a doctor to get some helpful tips.

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

People are three times more likely to undergo at-home colon cancer screening if they're provided a free test, a new study says. About 30% of patients mailed a free stool test kit completed their ...

People mailed a free stool test kit are three times more likely to undergo colon cancer screening About 30% of patients sent a free kit completed their screening within six months By comparison ...

The company’s main revenue source is Cologuard, a non-invasive pre- and colorectal cancer [CRC] screening test that was first ...

The test leverages polymerase chain reaction (PCR) technology to detect cancerous DNA in stool ... regular screening starting at age 45. "Mainz Biomed partners with Quest for colorectal cancer ...

Colorectal cancer (CRC) is the third most common cancer globally, with more than 1.9 million new cases reported in 2020, according to World Cancer Research Fund. The US Preventive Services Task Force ...

With colon cancer rates rising, advocates hope a newly approved blood test screening can help more people catch it early. “If we find it early, we have a lot more options in treating it,” said Dr.